Detalhe da pesquisa
1.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
2.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612799
3.
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial.
Haematologica
; 108(9): 2520-2525, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779591
4.
Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.
Acta Neuropathol
; 144(5): 1053-1055, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943573
5.
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 172(6): 914-22, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771088
6.
Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
J Neurosurg
; : 1-7, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277657
7.
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
Sci Rep
; 14(1): 13069, 2024 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38844820
8.
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
JCO Precis Oncol
; 8: e2300348, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513168
9.
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Blood Adv
; 6(6): 1941-1946, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008107
10.
Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation.
Ther Adv Hematol
; 13: 20406207221115005, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050938
11.
Routine Molecular Pathology Diagnostics in Precision Oncology.
Dtsch Arztebl Int
; 118(Forthcoming)2021 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536117
12.
The clinical benefit of molecular re-assessments in management of progressive lung cancer.
Transl Lung Cancer Res
; 10(3): 1582-1587, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889532
13.
Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
Front Oncol
; 11: 666014, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937079
14.
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
J Thorac Oncol
; 16(11): 1952-1958, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245914
15.
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study.
J Thorac Oncol
; 15(7): 1177-1189, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119917
16.
Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formation.
Infect Immun
; 77(8): 3234-43, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19487483
17.
Differential effects of short-chain fatty acids and iron on expression of iha in Shiga-toxigenic Escherichia coli.
Microbiology (Reading)
; 155(Pt 11): 3554-3563, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19684070
18.
Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.
J Bacteriol
; 190(1): 275-85, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17873042
19.
Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations.
Oncotarget
; 8(65): 108738-108759, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312564
20.
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.
Nat Med
; 23(1): 69-78, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27941792